A novel epithelial sodium channel gamma-subunit de novo frameshift mutation leads to Liddle syndrome

Clin Endocrinol (Oxf). 2007 Nov;67(5):801-4. doi: 10.1111/j.1365-2265.2007.02967.x. Epub 2007 Jul 18.

Abstract

Objective: Liddle syndrome is a rare autosomal-dominant monogenic form of hypertension caused by mutations in the C-termini of the epithelial sodium channel beta- or gamma-subunit encoded by SCNN1B and SCNN1G, respectively, and often presenting with a familial history of hypertension. The purpose of this study was to determine whether mutations of SCNN1B or SCNN1G were present in a patient clinically suspected to have Liddle syndrome with no familial history of hypertension.

Design and patients: We screened the C-terminus of SCNN1B and SCNN1G in the patient, and also screened for the mutation in his parents, 50 hypertensive patients and 50 controls.

Results: In this patient, no mutations were found in the C-terminus of SCNN1B. However, we found a frameshift mutation caused by an 'AGCTC' deletion at the 583 codon in SCNN1G. The frameshift resulted in a new termination site at the 585 codon of the gamma-subunit and the deletion of its PY motif. Neither his parents nor 50 randomly selected patients with hypertension nor 50 controls have the mutation, indicating that this is a de novo mutation and not a common genetic polymorphism.

Conclusion: The de novo mutation is the first reported frameshift of the gamma-subunit causing Liddle syndrome. These data imply that a familial history of hypertension is not an essential criterion for the diagnosis of Liddle syndrome.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Amino Acid Sequence
  • Base Sequence
  • Case-Control Studies
  • Epithelial Sodium Channels / genetics*
  • Frameshift Mutation*
  • Genes, Dominant
  • Heterozygote
  • Humans
  • Hypertension / genetics*
  • Male
  • Molecular Sequence Data

Substances

  • Epithelial Sodium Channels
  • SCNN1B protein, human